|
1）Karre K, Ljunggren HG, Piontek G, et al. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature. 1986; 319: 675-8
|
|
|
|
2）Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49＋ IL-2-activated natural killer cells. Nature. 1992; 358: 66-70
|
|
|
|
|
|
3）Lanier LL. NK cell recognition. Annu Rev Immunol. 2005; 23: 225-74
|
|
|
|
|
|
4）Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol. 2003; 3: 304-16
|
|
|
|
|
|
5）Mistry AR, O'Callaghan CA. Regulation of ligands for the activating receptor NKG2D. Immunology. 2007; 121: 439-47
|
|
|
|
|
|
6）Wu J, Song Y, Bakker AB, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999; 285: 730-2
|
|
|
|
|
|
7）Gilfillan S, Ho EL, Cella M, et al. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol. 2002; 3: 1150-5
|
|
|
|
|
|
8）Giorda R, Rudert WA, Vavassori C, et al. NKR-P1, a signal transduction molecule on natural killer cells. Science. 1990; 249: 1298-300
|
|
|
|
|
|
9）Iizuka K, Naidenko OV, Plougastel BF, et al. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol. 2003; 4: 801-7
|
|
|
|
|
|
10）Oldenborg PA, Zheleznyak A, Fang YF, et al. Role of CD47 as a marker of self on red blood cells. Science. 2000; 288: 2051-4
|
|
|
|
|
|
11）Blery M, Kubagawa H, Chen CC, et al. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA. 1998; 95: 2446-51
|
|
|
|
|
|
12）Cosman D, Fanger N, Borges L, et al. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 1997; 7: 273-82
|
|
|
|
|
|
13）Yotsumoto K, Okoshi Y, Shibuya K, et al. Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J Exp Med. 2003; 198: 223-33
|
|
|
|
|
|
14）Kanazawa N, Tashiro K, Inaba K, et al. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chain. J Biol Chem. 2003; 278: 32645- 52
|
|
|
|
|
|
15）Gorczynski R, Chen Z, Kai Y, et al. CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules. J Immunol. 2004; 172: 7744-9
|
|
|
|
|
|
16）Shiratori I, Ogasawara K, Saito T, et al. Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor. J Exp Med. 2004; 199: 525-33
|
|
|
|
|
|
17）Wright GJ, Cherwinski H, Foster-Cuevas M, et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol. 2003; 171: 3034-46
|
|
|
|
|
|
18）Zhang S, Cherwinski H, Sedgwick JD, et al. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol. 2004; 173: 6786-93
|
|
|
|
|
|
19）Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature. 1988; 331: 269-72
|
|
|
|
|
|
20）Reyburn HT, Mandelboim O, Vales-Gomez M, et al. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 1997; 386: 514-7
|
|
|
|
|
|
21）Cretney E, Degli-Esposti MA, Densley EH, et al. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J Exp Med. 1999; 190: 435-44
|
|
|
|
|
|
22）Wills MR, Ashiru O, Reeves MB, et al. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J Immunol. 2005; 175: 7457-65
|
|
|
|
|
|
23）Brown MG, Dokun AO, Heusel JW, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 2001; 292: 934-7
|
|
|
|
|
|
24）Arase H, Mocarski ES, Campbell AE, et al. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 2002; 296: 1323-6
|
|
|
|
|
|
25）Arase H, Lanier LL. Specific recognition of virus-infected cells by paired NK receptors. Rev Med Virol. 2004; 14: 83-93
|
|
|
|
|
|
26）Smith HR, Heusel JW, Mehta IK, et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA. 2002; 99: 8826-31
|
|
|
|
|
|
27）Foster-Cuevas M, Wright GJ, Puklavec MJ, et al. Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor. J Virol. 2004; 78: 7667-76
|
|
|
|
|
|
28）Langlais CL, Jones JM, Estep RD, et al. Rhesus rhadinovirus R15 encodes a functional homologue of human CD200. J Virol. 2006; 80: 3098-103
|
|
|
|
|
|
29）Shiratori I, Yamaguchi M, Suzukawa M, et al. Down-regulation of basophil function by human CD200 and human herpesvirus-8 CD200. J Immunol. 2005; 175: 4441-9
|
|
|
|
|
|
30）Voigt S, Mesci A, Ettinger J, et al. Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B: Clr-b missing-self axis. Immunity. 2007; 26: 617-27
|
|
|
|
|
|
31）Cosman D, Mullberg J, Sutherland CL, et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity. 2001; 14: 123-33
|
|
|
|
|
|
32）Dunn C, Chalupny NJ, Sutherland CL, et al. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med. 2003; 197: 1427-39
|
|
|
|
|
|
33）Stern-Ginossar N, Elefant N, Zimmermann A, et al. Host immune system gene targeting by a viral miRNA. Science. 2007; 317: 376-81
|
|
|
|
|